{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:05:50Z","timestamp":1777662350924,"version":"3.51.4"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Transplant."],"abstract":"<jats:p>Liver xenotransplantation is a potential strategy to address the shortage of donor livers, either as a temporary bridge to allotransplantation, bridge to native liver recovery, or destination therapy. Advances in genetic engineering and immunosuppression have enabled liver xenografts to evade hyperacute rejection, yet durable graft survival remains elusive. Profound thrombocytopenia, consumptive coagulopathy, and xenotransplantation-associated thrombotic microangiopathy limit long-term graft survival. Evidence from nonhuman primates, decedents, and recent clinical models suggests that hematologic and physiologic species incompatibilities (in addition to classical immune-mediated rejection) constitute additional barriers to successful liver xenotransplantation. These problems are driven by species-specific platelet\u2013endothelial interactions, dysregulated coagulation factor synthesis, and platelet sequestration within the xenograft. This review synthesizes lessons from decedent and primate xenoliver models, highlighting progress in this area to date, barriers to prolonged survival after liver xenotransplant, and directions for further research.<\/jats:p>","DOI":"10.3389\/frtra.2026.1783796","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:48:29Z","timestamp":1773384509000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Challenges and perspectives in xenoliver research: lessons from decedent and primate models"],"prefix":"10.3389","volume":"5","author":[{"given":"Zoe","family":"Hahn","sequence":"first","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasra","family":"Shirini","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Ladowski","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University School of Medicine","place":["Durham, NC, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael P.H.","family":"Meier","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Maryland School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"B1","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cgh.2017.11.045","article-title":"Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e70017","DOI":"10.1111\/xen.70017","article-title":"Systematic review and comparative outcomes analysis of NHP liver allotransplants and xenotransplants","volume":"32","author":"Shirini","year":"2025","journal-title":"Xenotransplantation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1111\/xen.70011","article-title":"Bridging therapies-ex vivo liver xenoperfusion and the role of machine perfusion: an update","volume":"32","author":"Czigany","year":"2025","journal-title":"Xenotransplantation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e70107","DOI":"10.1111\/xen.70107","article-title":"Functional xenogeneic liver support in a living human: promise, lessons, and next steps","volume":"33","author":"Meier","year":"2026","journal-title":"Xenotransplantation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jhep.2025.08.044","article-title":"Genetically engineered pig-to-human liver xenotransplantation","volume":"84","author":"Zhang","year":"2025","journal-title":"J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/MAT.0b013e31825f3446","article-title":"Liver support systems\u2013a review","volume":"58","author":"Podoll","year":"2012","journal-title":"Asaio J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0140-6736(24)00693-7","article-title":"Acute liver failure","volume":"404","author":"Maiwall","year":"2024","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/lt.21476","article-title":"Liver xenografts for the treatment of acute liver failure: clinical and experimental experience and remaining immunologic barriers","volume":"14","author":"Hara","year":"2008","journal-title":"Liver Transpl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0140-6736(11)61091-X","article-title":"Clinical xenotransplantation: the next medical revolution?","volume":"379","author":"Ekser","year":"2012","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1097\/TP.0000000000005372","article-title":"International xenotransplantation association (IXA) position paper on kidney xenotransplantation","volume":"109","author":"Meier","year":"2025","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm1171","article-title":"Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience","volume":"11","author":"Kuwaki","year":"2005","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.6002\/ect.2016.0099","article-title":"Anatomic peculiarities of pig and human liver","volume":"15","author":"Nykonenko","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e12814","DOI":"10.1111\/xen.12814","article-title":"Auxiliary liver xenotransplantation technique in a transgenic pig-to-non-human primate model: a surgical approach to prolong survival","volume":"30","author":"Lee","year":"2023","journal-title":"Xenotransplantation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e9411","DOI":"10.7759\/cureus.9411","article-title":"Comparative anatomical study between the human and swine liver and its importance in xenotransplantation","volume":"12","author":"Ntonas","year":"2020","journal-title":"Cureus"},{"key":"B16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/BF02828212","article-title":"Comparison of morphology and microstructural components of hepatic portal vein between human and pig","volume":"25","author":"Zhang","year":"2005","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.transproceed.2008.10.097","article-title":"Biomechanical study of hepatic portal vein in humans and pigs and its value in liver transplantation","volume":"41","author":"Wang","year":"2009","journal-title":"Transplant Proc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"H1796","DOI":"10.1152\/ajpheart.2000.279.4.H1796","article-title":"Methods for assessing hepatic distending pressure and changes in hepatic capacitance in pigs","volume":"279","author":"Kjekshus","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B19","volume-title":"Colloquium Series on Integrated Systems Physiology: From Molecule to Function to Disease. Hepatic Circulation: Physiology and Pathophysiology","author":"Lautt","year":"2009"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s41586-025-08799-1","article-title":"Gene-modified pig-to-human liver xenotransplantation","volume":"641","author":"Tao","year":"2025","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/TP.0b013e3181e98d51","article-title":"Hepatic function after genetically engineered pig liver transplantation in baboons","volume":"90","author":"Ekser","year":"2010","journal-title":"Transplantation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/00007890-199506270-00002","article-title":"The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure","volume":"59","author":"Makowa","year":"1995","journal-title":"Transplantation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1111\/ajt.14341","article-title":"Prolonged survival following pig-to-primate liver Xenotransplantation utilizing exogenous coagulation factors and costimulation blockade","volume":"17","author":"Shah","year":"2017","journal-title":"Am J Transplant"},{"key":"B24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/00007890-200010150-00001","article-title":"Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days","volume":"70","author":"Ramirez","year":"2000","journal-title":"Transplantation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1399-3089.2006.00346.x","article-title":"Selected physiologic compatibilities and incompatibilities between human and porcine organ systems","volume":"13","author":"Ibrahim","year":"2006","journal-title":"Xenotransplantation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1124\/dmd.111.040618","article-title":"Cytochrome P450 pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry","volume":"39","author":"Achour","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e12497","DOI":"10.1111\/xen.12497","article-title":"A review of pig liver xenotransplantation: current problems and recent progress","volume":"26","author":"Zhang","year":"2019","journal-title":"Xenotransplantation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e47273","DOI":"10.1371\/journal.pone.0047273","article-title":"Mechanisms of xenogeneic baboon platelet aggregation and phagocytosis by porcine liver sinusoidal endothelial cells","volume":"7","author":"Peng","year":"2012","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1399-3089.2004.00187.x","article-title":"O-linked glycosylation and functional incompatibility of porcine von willebrand factor for human platelet GPIb receptors","volume":"12","author":"Schulte Am Esch","year":"2005","journal-title":"Xenotransplantation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1097\/TP.0000000000001319","article-title":"Pig liver Xenotransplantation: a review of progress toward the clinic","volume":"100","author":"Cooper","year":"2016","journal-title":"Transplantation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/TP.0b013e31818410a3","article-title":"Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells","volume":"86","author":"Lin","year":"2008","journal-title":"Transplantation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/00007890-199703150-00023","article-title":"Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors","volume":"63","author":"Kopp","year":"1997","journal-title":"Transplantation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1399-3089.2008.00476.x","article-title":"Recombinant pig TFPI efficiently regulates human tissue factor pathways","volume":"15","author":"Lee","year":"2008","journal-title":"Xenotransplantation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1399-3089.2012.00717.x","article-title":"Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons","volume":"19","author":"Kim","year":"2012","journal-title":"Xenotransplantation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1097\/01.TP.0000121135.24688.A3","article-title":"Classical pathway complement destruction is not responsible for the loss of human erythrocytes during porcine liver perfusion","volume":"77","author":"Rees","year":"2004","journal-title":"Transplantation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1399-3089.2012.00695.x","article-title":"Identification of human preformed antibody targets in GTKO pigs","volume":"19","author":"Burlak","year":"2012","journal-title":"Xenotransplantation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1399-3089.2010.00605.x","article-title":"The fate of human platelets perfused through the pig liver: implications for xenotransplantation","volume":"17","author":"Burlak","year":"2010","journal-title":"Xenotransplantation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1097\/00007890-200205150-00016","article-title":"Porcine livers perfused with human blood mount a graft-versus-\"host\u201d reaction","volume":"73","author":"Rees","year":"2002","journal-title":"Transplantation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/bj2660313","article-title":"Scavenger functions of the liver endothelial cell","volume":"266","author":"Smedsr\u00f8d","year":"1990","journal-title":"Biochem J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/MOT.0000000000000459","article-title":"Liver xenotransplantation","volume":"22","author":"Patel","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e12517","DOI":"10.1111\/xen.12517","article-title":"The complex functioning of the complement system in xenotransplantation","volume":"26","author":"Zhou","year":"2019","journal-title":"Xenotransplantation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1399-3089.2010.00602.x","article-title":"An in vitro model of pig liver xenotransplantation\u2013pig complement is associated with reduced lysis of wild-type and genetically modified pig cells","volume":"17","author":"Hara","year":"2010","journal-title":"Xenotransplantation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jceh.2023.01.008","article-title":"Liver transplantation for acute liver failure- indication, prioritization, timing, and referral","volume":"13","author":"Biswas","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1097\/TP.0000000000004608","article-title":"Ct volumetry can be used for monitoring liver function recovery in auxiliary partial orthotopic liver transplantation","volume":"107","author":"Kirchner","year":"2023","journal-title":"Transplantation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"13622","DOI":"10.3389\/ti.2025.13622","article-title":"The future of pig liver Xenotransplantation","volume":"38","author":"Karadagi","year":"2025","journal-title":"Transpl Int"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e12658","DOI":"10.1111\/xen.12658","article-title":"The problem of the \u201c4th xenoantigen\u201d after pig organ transplantation in non-human primates may be overcome by expression of human \u201cprotective\u201d proteins","volume":"28","author":"Yamamoto","year":"2021","journal-title":"Xenotransplantation"},{"key":"B47","year":"2024"},{"key":"B48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.trim.2008.10.008","article-title":"Coagulation dysregulation as a barrier to xenotransplantation in the primate","volume":"21","author":"Lin","year":"2009","journal-title":"Transpl Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S0140-6736(68)91869-2","article-title":"Pig-to-baboon liver xenografts","volume":"291","author":"Calne","year":"1968","journal-title":"Lancet"},{"key":"B50","first-page":"1353","article-title":"Porcine-to-primate orthotopic liver transplantation","volume":"26","author":"Powelson","year":"1994","journal-title":"Transplant Proc"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1016\/S0041-1345(98)01256-1","article-title":"Auxiliary orthotopic xenogeneic liver transplantation using pigs for fulminant hepatic failure: with special reference to the technique and immunosuppression","volume":"30","author":"Hayashi","year":"1998","journal-title":"Transplant Proc"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1016\/j.transproceed.2005.09.186","article-title":"Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase)","volume":"37","author":"Ram\u00edrez","year":"2005","journal-title":"Transplant Proc"},{"key":"B53","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/xen.12111","article-title":"Increased transfusion-free survival following auxiliary pig liver xenotransplantation","volume":"21","author":"Yeh","year":"2014","journal-title":"Xenotransplantation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000374067","article-title":"Pig BMSCs transfected with human TFPI combat Species incompatibility and regulate the human TF pathway in vitro and in a rodent model","volume":"36","author":"Ji","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1111\/ajt.13647","article-title":"The effects of exogenous administration of human coagulation factors following pig-to-baboon liver xenotransplantation","volume":"16","author":"Navarro-Alvarez","year":"2016","journal-title":"Am J Transplant"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/SLA.0000000000001659","article-title":"A bridge to somewhere: 25-day survival after pig-to-baboon liver Xenotransplantation","volume":"263","author":"Shah","year":"2016","journal-title":"Ann Surg"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e12321","DOI":"10.1111\/xen.12321","article-title":"Cytokine profiles in Tibetan macaques following \u03b1-1, 3-galactosyltransferase-knockout pig liver xenotransplantation","volume":"24","author":"Zhang","year":"2017","journal-title":"Xenotransplantation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e0207272","DOI":"10.1371\/journal.pone.0207272","article-title":"Xenogeneic heterotopic auxiliary liver transplantation (XHALT) promotes native liver regeneration in a post-hepatectomy liver failure model","volume":"13","author":"Navarro-Alvarez","year":"2018","journal-title":"PLoS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/d41586-025-01209-6","article-title":"Pig livers for people: US regulator greenlights first safety trial","volume":"640","author":"Fieldhouse","year":"2025","journal-title":"Nature"},{"key":"B60","year":""},{"key":"B61","year":""}],"container-title":["Frontiers in Transplantation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2026.1783796\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:48:30Z","timestamp":1773384510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2026.1783796\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":61,"alternative-id":["10.3389\/frtra.2026.1783796"],"URL":"https:\/\/doi.org\/10.3389\/frtra.2026.1783796","relation":{},"ISSN":["2813-2440"],"issn-type":[{"value":"2813-2440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"article-number":"1783796"}}